Correlation Between Processa Pharmaceuticals and Acer Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Acer Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Acer Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and Acer Therapeutics, you can compare the effects of market volatilities on Processa Pharmaceuticals and Acer Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Acer Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Acer Therapeutics.

Diversification Opportunities for Processa Pharmaceuticals and Acer Therapeutics

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Processa and Acer is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Acer Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acer Therapeutics and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Acer Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acer Therapeutics has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Acer Therapeutics go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Acer Therapeutics

If you would invest  107.00  in Processa Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of  18.00  from holding Processa Pharmaceuticals or generate 16.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Processa Pharmaceuticals  vs.  Acer Therapeutics

 Performance 
       Timeline  
Processa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Processa Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Acer Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acer Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Acer Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Processa Pharmaceuticals and Acer Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Processa Pharmaceuticals and Acer Therapeutics

The main advantage of trading using opposite Processa Pharmaceuticals and Acer Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Acer Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer Therapeutics will offset losses from the drop in Acer Therapeutics' long position.
The idea behind Processa Pharmaceuticals and Acer Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA